30 phenotypes from 5 alleles in 4 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Lmo2tm1Thr/Lmo2tm1Thr either: (involves: 129P2/OlaHsd * MF1) or (involves: 129/Sv * 129P2/OlaHsd)	abnormal allantois morphology	J:19175
	abnormal cell death	J:19175
	abnormal dorsal aorta morphology	J:19175
	abnormal embryonic hematopoiesis	J:19175
	abnormal neural tube morphology	J:19175
	absent visceral yolk sac blood islands	J:19175
	decreased embryo size	J:19175
	delayed embryo turning	J:19175
	delayed somite formation	J:19175
	distended pericardium	J:19175
	embryonic lethality during organogenesis, complete penetrance	J:19175
	pale yolk sac	J:19175
	pallor	J:19175
	short rostral-caudal axis	J:19175
	small visceral yolk sac	J:19175
Lmo2tm2(cre)Thr/Lmo2+ involves: 129P2/OlaHsd * C57BL/6	abnormal common myeloid progenitor cell morphology	J:155870
	abnormal megakaryocyte progenitor cell morphology	J:155870
	decreased erythrocyte cell number	J:155870
	decreased granulocyte number	J:155870
	decreased hemoglobin content	J:155870
	decreased monocyte cell number	J:155870
	increased mean corpuscular volume	J:155870
	thrombocytopenia	J:155870
Lmo2tm3Thr/Lmo2tm4Thr Cd19tm1(cre)Thr/Cd19+ involves: 129S/SvEv	normal hematopoietic system phenotype	J:86869
	normal immune system phenotype	J:86869
Lmo2tm3Thr/Lmo2tm4Thr Rag1tm1(cre)Thr/Rag1+ involves: 129S/SvEv	normal hematopoietic system phenotype	J:86869
	normal immune system phenotype	J:86869
Lmo2tm3Thr/Lmo2tm4Thr Tg(Lck-cre)1Thr/0 involves: 129S/SvEv	normal hematopoietic system phenotype	J:86869
	normal immune system phenotype	J:86869
Lmo2tm4Thr/Lmo2tm4Thr involves: 129S/SvEv	prenatal lethality	J:59368
Tg(CD2-Lmo2)#Thr/0 involves: C57BL/6 * CBA	enlarged spleen	J:102058
	enlarged thymus	J:102058
	increased acute lymphoblastic leukemia incidence	J:102058
	premature death	J:102058